VCRE (Vicore Pharma Holding AB) Total Debt per Share: $0.00 (As of Mar. 2026)

What is Vicore Pharma Holding AB Total Debt per Share?

Vicore Pharma Holding AB VCRE -7.54% 13 Total Debt per Share is $0.00 as of Mar. 2026. GuruFocus rates VCRE with a GF Score™ of 13/100. The stock has 5 warning signs investors should review.

$0.00 (As of Mar. 2026)

Total Debt per Share is calculated as total debt divided by Shares Outstanding (EOP). Total debt is calculated as Long-Term Debt & Capital Lease Obligation plus Short-Term Debt & Capital Lease Obligation. Vicore Pharma Holding AB's Total Debt Per Share for the quarter that ended in Mar. 2026 was $0.00.

Vicore Pharma Holding AB Total Debt per Share Related Terms

Vicore Pharma Holding AB Total Debt per Share Historical Data

* Premium members only.

The historical data trend for Vicore Pharma Holding AB's Total Debt per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Vicore Pharma Holding AB Total Debt per Share Chart

Vicore Pharma Holding AB Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

Total Debt per Share

Get a 7-Day Free Trial

0.00

Vicore Pharma Holding AB Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
Total Debt per Share	Get a 7-Day Free Trial															0.00	0.00	0.00	0.00	0.00

13GF Score

Vicore Pharma Holding AB VCRE

Total Debt per Share is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Vicore Pharma Holding AB Total Debt per Share Calculation

Vicore Pharma Holding AB's Total Debt Per Share for the fiscal year that ended in Dec. 2025 is calculated as:

Total Debt Per Share	=	(Long-Term Debt & Capital Lease Obligation	+	Short-Term Debt & Capital Lease Obligation)	/	Shares Outstanding (EOP)
	=	(0.00	+	0.00)	/	281.53
	=	0.00

Vicore Pharma Holding AB's Total Debt Per Share for the quarter that ended in Mar. 2026 is calculated as:

Total Debt Per Share	=	(Long-Term Debt & Capital Lease Obligation	+	Short-Term Debt & Capital Lease Obligation)	/	Shares Outstanding (EOP)
	=	(0.00	+	0.00)	/	281.53
	=	0.00

Frequently Asked Questions Learn more about Total Debt per Share →

What does a Total Debt per Share of $0.00 mean?

Vicore Pharma Holding AB (VCRE) has a Total Debt per Share of $0.00 as of Mar. 2026. Total debt per share equals the per-share value of a company's long-term and short-term debt. View historical data on Vicore Pharma Holding AB and its competitors.

Is Vicore Pharma Holding AB's Total Debt per Share too high?

Vicore Pharma Holding AB's current Total Debt per Share is $0.00. Overall, Vicore Pharma Holding AB has a GF Score™ of 13/100, reflecting its overall financial health beyond just this single metric.

How does Vicore Pharma Holding AB's Total Debt per Share compare to ?

Vicore Pharma Holding AB's Total Debt per Share of $0.00 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Total Debt per Share for a Biotechnology company?

A good Total Debt per Share depends on the Biotechnology industry context. However, Total Debt per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Total Debt per Share mean?

A high Total Debt per Share can signal that a stock is expensive relative to its fundamentals. Total debt per share equals the per-share value of a company's long-term and short-term debt. View historical data on Vicore Pharma Holding AB and its competitors. Vicore Pharma Holding AB's current Total Debt per Share is $0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Vicore Pharma Holding AB stock overvalued right now?

Vicore Pharma Holding AB (VCRE) has a current Total Debt per Share of $0.00. The current Total Debt per Share is $0.00. Vicore Pharma Holding AB's overall GF Score™ is 13/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Total Debt per Share calculated?

Total Debt per Share is calculated from a company's financial statements. For Vicore Pharma Holding AB (VCRE), the current Total Debt per Share is $0.00 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Vicore Pharma Holding AB Business Description

Industry Healthcare Biotechnology

Comparable Companies

Other Exchanges VICO:Sweden 6Y4:Germany

Address Kornhamnstorg 53, Stockholm, SWE, 111 27

Website https://www.vicorepharma.com

Vicore Pharma Holding AB is a clinical-stage biopharmaceutical company developing a new class of disease-modifying therapies for respiratory and fibrotic diseases, including idiopathic pulmonary fibrosis (IPF). Its main program, buloxibutid, is an oral angiotensin II type 2 receptor agonist that has received Orphan Drug and Fast Track designation from the U.S. Food and Drug Administration and is currently being evaluated in the 52-week Phase 2b ASPIRE trial in IPF. Currently, Vicore is operating mainly in Sweden.

13GF Score

Get the complete analysis for VCRE

Total Debt per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$15.03

Price

View VCRE Analysis

See Total Debt per Share data for all stocks →